Fig. 4
From: Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
ROC curve analyses for identifying HCC patients from CHB patients and healthy controls. (a) ROC curve analyses of serum CASC7 and AFP for distinguishing HCC patients from CHB patients. (b) ROC curve analyses of serum CASC7 and AFP for distinguishing HCC patients from normal controls. (c) ROC curve analyses of serum CASC7 and AFP for distinguishing HCC patients from CHB patients and normal controls. ROC: receiver operating characteristic, HCC: hepatocellular carcinoma, CHB: chronic hepatitis B, CASC7: cancer susceptibility candidate 7, AFP: alpha fetoprotein